Nasic (Xylometazoline Hydrochloride, Dexpanthenol)

Xylometazoline Hydrochloride acts as a selective α‑adrenergic agonist. By binding to α‑receptors on the blood vessels of the nasal lining, it triggers vasoconstriction, which reduces swelling and opens the airway, allowing easier breathing during episodes of congestion.

The exact dosing regimen for Nasic is determined by the prescribing healthcare professional based on the patient’s age, severity of symptoms, and clinical judgment. Users should follow the label instructions and the prescriber’s guidance without exceeding the recommended number of sprays per day.

Safety data for Nasic in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their physician before using the product to weigh potential benefits against any uncertain risks.

To request Nasic, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with single‑ingredient decongestants such as oxymetazoline, Nasic adds dexpanthenol, which helps moisturise and repair the nasal mucosa. This combination may reduce the feeling of dryness that some users experience with plain vasoconstrictors, while providing comparable rapid relief of congestion.

Nasic should be stored at room temperature, ideally below 25 °C. Keep the bottle tightly closed in its original packaging, protect it from direct sunlight, moisture and extreme heat to maintain product stability and effectiveness.

Nasic is applied as a nasal spray. The user gently inserts the tip into one nostril, tilts the head slightly forward, and presses the pump to deliver the recommended number of sprays. The same procedure is repeated in the other nostril if instructed by the prescriber.

Serious adverse events, although rare, can include severe hypertension, cardiac arrhythmias, nasal ulceration or perforation with prolonged use, and anaphylactic reactions. Any sudden increase in blood pressure, chest pain, severe nosebleeds, or signs of an allergic reaction should prompt immediate medical attention.

Nasic should be avoided in children younger than 2 years, in individuals with known hypersensitivity to xylometazoline, dexpanthenol, or any excipients, and in patients taking monoamine oxidase inhibitors or other potent sympathomimetics without medical supervision.